Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG.

Antiviral therapy - 1 Jan 2006

Abecasis Ana B, Deforche Koen, Bacheler Lee T, McKenna Paula, Carvalho Ana Patricia, Gomes Perpétua, Vandamme Anne-Mieke, Camacho Ricardo Jorge

Abstract excerpt

OBJECTIVE: To compare baseline susceptibility to protease inhibitors among HIV-1 isolates of subtypes C, F, G and CRF02_AG, and to identify polymorphisms that determine the differences in susceptibility. METHODS: A total of 42 samples of drug-naive patients infected with subtypes G (n=19), CRF02_AG (n = 10), F (n = 6) and C (n = 7) were phenotyped and genotyped with the Antivirogram and the ViroSeq 2.0 genotyping...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV Protease
Share to HIV Protease Inhibitors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Indinavir

Share to Nelfinavir

Share to Pyridines

Share to Pyrones

Share to Ritonavir

Share to Sulfonamides

Source

Identifiers

PMID: 16964826

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG.PMID 16964826Read ↗

Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G.Semantic proximity Read ↗

Integrative Computational Approaches for Understanding Drug Resistance in HIV-1 Protease Subtype CSemantic proximity Read ↗

Characterization of protease resistance-associated mutations in HIV type 1 drug-naive patients following the increasing prevalence of the CRF02_AG strain in Morocco.Semantic proximity Read ↗

Drug resistance and genetic transmission characteristics of HIV-1 CRF59_01B in infected patients in Guangdong Province, China.Semantic proximity Read ↗

APOBEC-Induced Mutations at Initiation of Cabotegravir + Rilpivirine for Two Patients Infected by HIV-1 Subtype CRF02: The Interest of Systematic Genotyping.Semantic proximity Read ↗

Characterization of HIV-1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia.Semantic proximity Read ↗

Genetic variation at NNRTI resistance-associated positions in patients infected with HIV-1 subtype C.Semantic proximity Read ↗

Impact of Changes Over Time in the Stanford University Genotypic Resistance Interpretation Algorithm.Semantic proximity Read ↗

HIV genotypes and primary drug resistance among HIV-seropositive blood donors in Brazil: role of infected blood donors as sentinel populations for molecular surveillance of HIV.Semantic proximity Read ↗

Development and performance of conventional HIV-1 phenotyping (Antivirogram®) and genotype-based calculated phenotyping assay (virco®TYPE HIV-1) on protease and reverse transcriptase genes to evaluate drug resistance.Semantic proximity Read ↗

Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.Semantic proximity Read ↗

Prediction of drug-resistance in HIV-1 subtype C based on protease sequences from ART naive and first-line treatment failures in North India using genotypic and docking analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.